Expression and Characterization of Truncated Recombinant Human Cytochrome P450 2J2

• Published in: Toxicological research (Seoul) Vol. 30; no. 1; pp. 33 - 38
• Main Authors: Park, Hyoung-Goo, Lim, Young-Ran, Han, Songhee, Kim, Donghak
• Format: Journal Article
• Language: English
• Published: Singapore 한국독성학회 01.03.2014; Springer Singapore; The Korean Society Of Toxicology
• Subjects: Biomedicine; Original Article; Pharmacology/Toxicology; 예방의학; Terfenadine; N-terminal truncation; P450 2J2
• ISSN: 1976-8257; 2234-2753; 2234-2753
• DOI: 10.5487/TR.2014.30.1.033

The human cytochrome P450 2J2 catalyzes an epoxygenase reaction to oxidize various fatty acids including arachidonic acid. In this study, three recombinant enzyme constructs of P450 2J2 were heterologously expressed in Escherichia coli and their P450 proteins were successfully purified using a Ni 2+ -NTA affinity column. Deletion of 34 amino acid residues in N-terminus of P450 2J2 enzyme (2J2-D) produced the soluble enzyme located in the cytosolic fraction. The enzymatic analysis of this truncated protein indicated the typical spectral characteristics and functional properties of P450 2J2 enzyme. P450 2J2-D enzymes from soluble fraction catalyzed the oxidation reaction of terfenadine to the hydroxylated product. However, P450 2J2-D enzymes from membrane fraction did not support the P450 oxidation reaction although it displayed the characteristic CO-binding spectrum of P450. Our finding of these features in the N-terminal modified P450 2J2 enzyme could help understand the biological functions and the metabolic roles of P450 2J2 enzyme and make the crystallographic analysis of the P450 2J2 structure feasible for future studies.